Love Pharma Completes the Acquisition of MicroDoz Therapy
LOVE Pharma Co. has announced the completion of its acquisition of MicroDoz Theraphy Inc. ("MicroDoz"). Love Pharma holds exclusive manufacturing, marketing, packaging, selling, and distribution licenses in Europe, the United Kingdom, and North America. Under the terms of the share exchange agreement (the "Share Exchange Agreement") entered into among the company, MicroDoz, and the MicroDoz shareholders (the "MicroDoz Shareholders"), the company will issue a total of 20,000,000 common shares of Love (the "Love Shares") on a pro-rata basis at a deemed price of CAD $0.05 per Love Share for aggregate proceeds o...
